In this video, myeloma practitioners Dr. Joseph Mikhael (IMF Chief Medical Officer) and Kimberly Noonan, DNP, RN, ANP-BC, AOCN® (a member of IMF's Nurse Leadership Board) explain that Darzalex Faspro® is administered subcutaneously. They highlight the drug's benefits as well as potential side effects. Myeloma patients who have undergone this treatment discuss quality of life issues that treatment with Darzalex Faspro treatment has provided them.
Please subscribe to our channel!
Subscribe to International Myeloma Foundation: bit.ly/XlUtPE
Visit our website at: www.myeloma.org
Find us online:
Facebook: / myeloma
Twitter: @IMFMyeloma ( / imfmyeloma )
Instagram: @imfmyeloma ( / imfmyeloma )
LinkedIn: / international-myeloma-... )
Support the IMF! bit.ly/WskQHC
Category
Nonprofits & Activism
License
Standard KZread License